English
Home > Products > CAS NO 232941-14-9

China CAS NO 232941-14-9 Factory

Our firm sticks to the basic principle of "Quality is the life of your company, and status will be the soul of it" for CAS NO 232941-14-9,232941-14-9,Prucalopride intermediate,Prucalopride advance intermediate,Methyl 4-(acetylaMino)-3-broMo, Our mission should be to assist you build long-lasting interactions with the purchasers as a result of the ability of promotional solutions.
CAS NO 232941-14-9, Our company warmly invites domestic and overseas customers to come and negotiate business with us. Allow us to join hands to create a brilliant tomorrow! We are looking forward to cooperating with you sincerely to achieve a win-win situation. We promise to try our best to deliver you with high quality and efficient services.

Related Products

Hot Products

  • Vitamin E Acetate

    Vitamin E Acetate

    Product Name:​Vitamin E Acetate
    Molecular Formula:C31H52O3
    Molecular Weight:472.75
    CAS Registry Number:7695-91-2
    EINECS:231-710-0
  • Disodium hydrogen phosphate dihydrate

    Disodium hydrogen phosphate dihydrate

    Product Name:Disodium hydrogen phosphate dihydrate
    Molecular Formula:2Na.HO4P.2H2O
    Molecular Weight:177.99
    CAS Registry Number:10028-24-7
  • Methyl-, 3',5'-dibenzoate, (2'R)Cytidine, N-benzoyl-2'-deoxy-2'-fluoro-2'-

    Methyl-, 3',5'-dibenzoate, (2'R)Cytidine, N-benzoyl-2'-deoxy-2'-fluoro-2'-

    Product Name:Methyl-, 3',5'-dibenzoate, (2'R)Cytidine, N-benzoyl-2'-deoxy-2'-fluoro-2'-
    Molecular Formula:C31H26FN3O7
    Molecular Weight:571.55
    CAS Registry Number:817204-32-3
  • Vancomycin HCl Injection

    Vancomycin HCl Injection

    Product Name:Vancomycin HCl Injection
    Dosage:0.5g
    Application:Antibiotic
  • 5-Amino-2-fluoropyridine

    5-Amino-2-fluoropyridine

    Product Name:5-Amino-2-fluoropyridine
    Molecular Formula:C5H5FN2
    Molecular Weight:112.11
    CAS Registry Number:1827-27-6
  • HBTU

    HBTU

    Product Name:HBTU
    Molecular Formula:C11H16F6N5OP
    Molecular Weight:379.25
    CAS Registry Number:94790-37-1
  • Related Blog
  • Reviews

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept